The Pivotal Role of NF-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26167883 ↗At a glance
Übersichtsarbeit in International Journal of Molecular Sciences, 2025. Written by Vanajothi Ramar and 3 co-authors. Institution: Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA. Major MEDLINE topics: Glioblastoma, NF-kappa B, Brain Neoplasms. Cited 17 times so far (Crossref); 148 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, NIMHD NIH HHS, NIH NIGMS.
Abstract (original language)
Glioblastoma multiforme (GBM) is the most aggressive and lethal primary brain tumor in adults, characterized by high intratumoral heterogeneity, therapy resistance, and poor prognosis. Nuclear factor-κB (NF-κB) signaling plays a pivotal role in GBM pathogenesis by promoting proliferation, invasion, inflammation, immune evasion, and treatment resistance. This review provides a comprehensive overview of canonical and non-canonical NF-κB signaling pathways and their molecular mechanisms in GBM, with a focus on their regulation in glioma stem-like cells (GSCs), interactions with key oncogenic factors (including STAT3, FOSL1, and TRPM7), and roles in maintaining tumor stemness, metabolic adaptation, and angiogenesis. We further discuss the reciprocal regulatory dynamics between NF-κB and non-coding RNAs (ncRNAs), particularly microRNAs, highlighting novel ncRNA-mediated epigenetic switches that shape GBM cell plasticity and subtype specification. Additionally, we examine the influence of NF-κB in modulating the tumor microenvironment (TME), where it orchestrates pro-tumorigenic cytokine production, immune cell reprogramming, and stromal remodeling. Finally, we review current NF-κB-targeting therapeutic strategies in GBM, including clinical trial data on small-molecule inhibitors and combinatorial approaches. Understanding the multifaceted roles of NF-κB in GBM offers new insights into targeted therapies aimed at disrupting tumor-promoting circuits within both cancer cells and the TME.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA.
- RCMI Cancer Research Center and Department of Chemistry, Xavier University, 1 Drexel Dr, New Orleans, LA 70125, USA.
ORCID profiles: Shanchun Guo
Funding
- NIGMS NIH HHS
- NIMHD NIH HHS
- NIH NIGMS
- Minority Health and Health Disparities (NIMHD)
- RCMI
Cite
APA
Ramar, V., Guo, S., Wang, G., & Liu, M. (2025). The Pivotal Role of NF-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167883
Vancouver
Ramar V, Guo S, Wang G, Liu M. The Pivotal Role of NF-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167883
BibTeX
@article{Ramar2025,
author = {Ramar, Vanajothi and Guo, Shanchun and Wang, Guangdi and Liu, Mingli},
title = {The Pivotal Role of NF-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26167883}
}
EUVIMED